About 5 results found for searched term "MI-219" (0.118 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40973 | MI-219 | Mdm2 |
| MI-219 is a potent, highly selective, orally active MDM2 inhibitor that effectively blocks the interaction of MDM2 with p53 (Ki=5nM), and its selectivity for MDM2 is 10,000 times higher than that of MDMX, which has anticancer activity. | ||
| M58553 | Indoramin | Adrenergic Receptor |
| Indoramine; Wy 21901 | ||
| Indoramin is a selective α1A-adrenoceptor antagonist. | ||
| M28576 | PS121912 | Vitamin |
| PS121912 is a selective vitamin D receptor (VDR)-coregulator inhibitor. PS121912 has acceptable metabolic stability in vivo. PS121912 can be used for the research of cancer. | ||
| M30020 | EN219 | E1/E2/E3 Enzyme |
| EN219 is a moderately selective synthetic covalent ligand against an N-terminal cysteine (C8) of RNF114 with an IC50 of 470 nM. EN219 inhibits RNF114-mediated autoubiquitination and p21 ubiquitination. | ||
| M42945 | Decyclohexanamine-Exatecan | Others |
| Decyclohexanamine-Exatecan is a Camptothecin derivative, compound a, extracted from patent WO2020219287 A1. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
